Control of the innate immune response by the mevalonate pathway
Department of Medicine, Division of Infectious Diseases and Immunology; Department of Medicine, Division of Rheumatology
Deficiency in mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate, a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylation, a protein post-translational modification that is catalyzed by protein geranylgeranyl transferase I (GGTase I). Pyrin is an innate immune sensor that forms an active inflammasome in response to bacterial toxins. Mutations in MEFV (encoding human PYRIN) result in autoinflammatory familial Mediterranean fever syndrome. We found that protein geranylgeranylation enabled Toll-like receptor (TLR)-induced activation of phosphatidylinositol-3-OH kinase (PI(3)K) by promoting the interaction between the small GTPase Kras and the PI(3)K catalytic subunit p110delta. Macrophages that were deficient in GGTase I or p110delta exhibited constitutive release of interleukin 1beta that was dependent on MEFV but independent of the NLRP3, AIM2 and NLRC4 inflammasomes. In the absence of protein geranylgeranylation, compromised PI(3)K activity allows an unchecked TLR-induced inflammatory responses and constitutive activation of the Pyrin inflammasome.
DOI of Published Version
Nat Immunol. 2016 Aug;17(8):922-9. doi: 10.1038/ni.3487. Epub 2016 Jun 6. Link to article on publisher's site
Jiang Z, Foster CE, Li AS, Zhang X, Gavin RM, Forde SD, Germain G, Carpenter SB, Silverman NS, Gravallese EM, Fitzgerald KA, Golenbock DT, Wang D. (2016). Control of the innate immune response by the mevalonate pathway. UMass Chan Medical School Faculty Publications. https://doi.org/10.1038/ni.3487. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/1026